TRENDS IN LABORATORY-CONFIRMED PNEUMOCOCCAL MENINGITIS AFTER INTRODUCTION OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) INTO THE NATIONAL IMMUNIZATION PROGRAMME IN CAMEROON (ID 299)

Session Name
Vaccines - Impact of Vaccine programs and Serotype Replacement
Presenter
  • John Njuma Libwea, Finland
Authors
  • John Njuma Libwea, Finland
  • Mark Fletcher, United States of America
  • Paul Koki Ndombo, Cameroon
  • Shiro-Sinata Koulla, Cameroon
  • Jo Southern, United States of America
  • Bradford D. Gessner, United States of America